The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Quantitative Methods for Assessing Drug Synergism
Open accessAbstract
Two or more drugs that individually produce overtly similar effects will sometimes display greatly enhanced effects when given in combination. When the combined effect is greater than that predicted by their individual potencies, the combination is said to be synergistic. A synergistic interaction allows the use of lower doses of the combination constituents, a situation that may reduce adverse reactions. Drug combinations are quite common in the treatment of cancers, infections, pain, and many other diseases and situations. The determination of synergism is a quantitative pursuit that involves a rigorous demonstration that the combination effect is greater than that which is expected from the individual drug's potencies. The basis of that demonstration is the concept of dose equivalence, which is discussed here and applied to an experimental design and data analysis known as isobolographic analysis. That method, and a related method of analysis that also uses dose equivalence, are presented in this brief review, which provides the mathematical basis for assessing synergy and an optimization strategy for determining the dose combination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
(1953) · PubMed · Cited by 942
An Overview of Drug Combination Analysis with Isobolograms
Tallarida, R. J. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104117 · Cited by 505
Self-citationComplementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
Raffa, R. B., Friderichs, E., Reimann, W., Shank, R. P., Codd, E. E., Vaught, J. L., Jacoby, H. I., & Selve, N. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39454-1 · Cited by 442
Die quantitativen Probleme der Pharmakologie
Loewe, S. (1928) · Ergebnisse der Physiologie · doi:10.1007/bf02322290 · Cited by 229
Isobolographic analysis of interactions: an update on applications and utility
Gessner, P. K. (1995) · Toxicology · doi:10.1016/0300-483x(95)03210-7 · Cited by 221
Wilcox, G. L., Carlsson, K.-H., Jochim, A., & Jurna, I. (1987) · Brain Research · doi:10.1016/0006-8993(87)90992-9 · Cited by 220
Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles
Grabovsky, Y., & Tallarida, R. J. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067264 · Cited by 183
Self-citationInteractions between drugs and occupied receptors
Tallarida, R. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.08.002 · Cited by 130
Self-citationTesting for synergism over a range of fixed ratio drug combinations: Replacing the isobologram
Tallarida, R. J., & Raffa, R. B. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02271-6 · Cited by 117
Self-citationFairbanks, C. A., & Wilcox, G. L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38063-2 · Cited by 111
Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction
Porreca, F., Jiang, Q., & Tallarida, R. J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90190-h · Cited by 111
Self-citationResponse Surface Analysis of Synergism Between Morphine and Clonidine
Tallarida, R. J., Stone, D. J., McCary, J. D., & Raffa, R. B. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38100-5 · Cited by 85
Self-citationTallarida, R. J., & Raffa, R. B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.011 · Cited by 57
Self-citationTheory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine
Tallarida, R. J., Kimmel, H. L., & Holtzman, S. G. (1997) · Psychopharmacology · doi:10.1007/s002130050417 · Cited by 39
Self-citationSynergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat
Kimmel, H. L., Tallarida, R. J., & Holtzman, S. G. (1997) · Psychopharmacology · doi:10.1007/s002130050416 · Cited by 26
Self-citation
Cited by
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Couturier, C. P., Ayyadhury, S., Le, P. U., Nadaf, J., Monlong, J., Riva, G., Allache, R., Baig, S., Yan, X., Bourgey, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17186-5 · Cited by 569
Shannon, E., & Abu-Ghannam, N. (2016) · Marine Drugs · doi:10.3390/md14040081 · Cited by 385
Alassane-Kpembi, I., Schatzmayr, G., Taranu, I., Marin, D., Puel, O., & Oswald, I. P. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1140632 · Cited by 329
Clinical development of new drug–radiotherapy combinations
on behalf of the NCRI CTRad Academia-Pharma Joint Working Group, Sharma, R. A., Plummer, R., Stock, J. K., Greenhalgh, T. A., Ataman, O., Kelly, S., Clay, R., Adams, R. A., Baird, R. D., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.79 · Cited by 320
Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 276
Metadata
- Authors
- Tallarida, R. J.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-11-01
- Volume
- 2
- Issue
- 11
- Pages
- 1003-1008
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2126821513
- Cited by
- 378
- References
- 17
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.